Literature DB >> 31653352

Assessment of Predictors of Left Atrial Volume Response to a Transcatheter InterAtrial Shunt Device (from the REDUCE LAP-HF Trial).

Thomas C Hanff1, David M Kaye2, Christopher S Hayward3, Martijn C Post4, Filip Malek5, Gerd Hasenfuβ6, Finn Gustafsson7, Daniel Burkhoff8, Sanjiv J Shah9, Sheldon E Litwin10, Rami Kahwash11, Scott L Hummel12, Barry A Borlaug13, Scott D Solomon14, Carolyn S P Lam15, Jan Komtebedde16, Frank E Silvestry17.   

Abstract

In patients with heart failure and preserved or mildly reduced ejection fractions (EF ≥40%), implantation of an interatrial shunt device (IASD) resulted in heterogenous changes of the left atrial (LA) volume. Baseline characteristics that correlate with a favorable decrease in LA volume are unknown. We hypothesized that a larger ratio of left to right atrial volume at baseline would correlate strongly with LA volume decongestion following IASD implantation. Reduce Elevated LA Pressure in Patients With Heart Failure was a multicenter study of the safety and feasibility of IASD implantation. Sixty-four patients with EF ≥40% underwent device implantation along with baseline conventional echocardiograms, speckle tracking echocardiography, and resting and exercise hemodynamics. Higher LA compliance (-4.2%, p = 0.048) and right atrial reservoir strain (-0.8%, p = 0.005) were independently associated with a percent decrease in the systolic LA volume index from baseline to 6-months. In conclusion, greater LA volume reduction following IASD implantation is associated with higher baseline compliance of the left atrium and higher reservoir strain of the right atrium.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31653352     DOI: 10.1016/j.amjcard.2019.09.019

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

Review 1.  The future of heart failure with preserved ejection fraction : Deep phenotyping for targeted therapeutics.

Authors:  Frank R Heinzel; Sanjiv J Shah
Journal:  Herz       Date:  2022-06-29       Impact factor: 1.740

2.  Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation.

Authors:  Yogesh N V Reddy; Masaru Obokata; Frederik H Verbrugge; Grace Lin; Barry A Borlaug
Journal:  J Am Coll Cardiol       Date:  2020-09-01       Impact factor: 24.094

Review 3.  Device-based treatment options for heart failure with preserved ejection fraction.

Authors:  Chihiro Miyagi; Takuma Miyamoto; Jamshid H Karimov; Randall C Starling; Kiyotaka Fukamachi
Journal:  Heart Fail Rev       Date:  2021-01-12       Impact factor: 4.214

4.  Impact of Interatrial Shunts on Invasive Hemodynamics and Exercise Tolerance in Patients With Heart Failure.

Authors:  Jan M Griffin; Barry A Borlaug; Jan Komtebedde; Sheldon E Litwin; Sanjiv J Shah; David M Kaye; Elke Hoendermis; Gerd Hasenfuß; Finn Gustafsson; Emil Wolsk; Nir Uriel; Daniel Burkhoff
Journal:  J Am Heart Assoc       Date:  2020-08-15       Impact factor: 5.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.